Prisma Health Pharmacy Residency Research Showcase 2023: Parts 1 & 2 (Home Study) (P)

Target Audience: Pharmacists

Fee: $30 for whole program (or each part is $18 per)

To register for either part 1 or part 2, click the drop down, and choose "Separate Pay".

Flyer: Click Here

Speakers and Topics:

* Please scroll down to view the presentation title and learning objectives for pharmacists

Credit Hours Available: This program was pre-recorded. Part 1 is accredited for 1.75 contact hours or 0.175 CEUS, video runtime is 1 hour 51 minutes long; Part 2 is accreded for 1.75 contact hours or 0.175 CEUs, video runtime is 1 hour 50 minutes long.

How to Earn Credit: Participants must 1) read the learning objectives and faculty disclosures, 2) listen to the video presentation and the interactivity, and 3) complete the evaluation form. To receive credit, you must provide your date of birth and NABP number. CE credit will be submitted to the NABP CE Monitor.

Required Computer Hardware/Software:

Please ensure the computer system you plan to use meets the following minimum requirements:

Operating System: Windows, Mac OS and Linux
Internet Browser: Internet Explorer 7.0 or higher; Mozilla Firefox 3.0 or higher; Google Chrome
Computer Speakers or headphones connected to your computer
Broadband Internet Connection: Cable, High-speed DSL or T1
Monitor Screen Resolution: 320x480 or higher
Media Viewing Requirements: Adobe Reader, Microsoft Power Point and HTML

Privacy and Confidentiality: Information received by the University of South Carolina College of Pharmacy for continuing education (CE) programs will be maintained in a confidential and secure manner. In order for continuing education credit to be submitted to the NABP CPE Monitor, personal information such as your NABP e-Profile ID and day and month of birth will be required along with your name and contact information.

Provider Contact Information: For questions regarding this continuing education activity, please contact our office at CE@cop.sc.edu or 803-777-9979.

Pharmacy Residency Research Showcase 2023: Part 1

Evaluating the Addition of Atypical Antipsychotics to Continuous Infusion Propofol Therapy

Jake Crocker, PharmD; PGY1 Acute Care Pharmacy Resident

Review and quantify overall effectiveness of atypical antipsychotics on reduction in the amount of continuous infusion propofol utilized in the ICU

Incidence and Predictors of Acute Kidney Injury in Patients Receiving Hypertonic Saline in the Neuroscience Intensive Care Unit

Allyson Barnett, PharmD; PGY2 Critical Care Pharmacy Resident

Recognize potential contributors to acute kidney injury in patients receiving hypertonic saline

Evaluating the safety and effectiveness of long-term antibiotic suppression in patients with left ventricular assist devices

Kelsey D. Hamlin, PharmD; PGY1 Acute Care Pharmacy Resident

Describe the safety and effectiveness of chronic antibiotic suppression therapy for patients with a left ventricular assist device (LVAD)

Evaluating Dalbavancin Suppression Therapy in Patients at High Risk for Recurrent Infections

Michael K. Shaw, PharmD; PGY2 Infectious Diseases Pharmacy Resident

Determine the proportion of patients who experienced treatment-emergent adverse events (TEAE) while receiving dalbavancin suppressive therapy

Efficacy and Safety of SGLT2 Inhibitors in Patients with a Left Ventricular Assist Device

Erik Preheim, PharmD; PGY1 Outpatient Focused Pharmacy Resident

Describe the safety and efficacy of SGLT2 inhibitors observed in patients supported by an LVAD

Treatment Outcome of Cabotegravir/Rilpivirine Long-Acting Injectable in Obese Patients

Y. Vivian Tsai, PharmD; Infectious Diseases Pharmacy Fellow

Discuss the clinical treatment outcomes of cabotegravir/rilpivirine long-acting injectable when administered every 8 weeks in obese patients

Impact of a Procalcitonin Guided Antibiotic Management Strategy in Pediatric Sickle Cell Patients with Fever

Hannah Robinson, PharmD; PGY2 Pediatric Pharmacy Resident

Identify the utility of procalcitonin’s on antibiotic duration of therapy in pediatric sickle cell patients with fever

Pharmacy Residency Research Showcase 2023: Part 2

CSF Lactate as a Surrogate Marker for Infection in Patients with External Ventricular Drains and Ventriculoperitoneal Shunts

Abbie L. Blunier, PharmD; PGY1 Pharmacy Resident

Describe the role of cerebrospinal fluid (CSF) lactate concentration as an indicator of infection in patients who have an external ventricular drain (EVD) or ventriculoperitoneal (VP) shunt

Requirements for true access to SGLT2 inhibitors in a heart failure population

Lucy Rinehuls, PharmD; PGY1 Outpatient Focused Pharmacy Resident

Identify barriers to consistent, sustainable access of SGLT2 inhibitors for the treatment of heart failure

Impact of a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD

Ben Tabor, PharmD; PGY2 Cardiology Pharmacy Resident

Describe the impact of a conservative anticoagulation protocol following GIB on clinical outcomes in patients with a HM3 LVAD

Pharmacist Utilization of MRSA PCR Nasal Swabs for anti-MRSA Therapy Discontinuation

Tamia Jones, PharmD; PGY2 Internal Medicine Pharmacy Resident

Determine the difference in time to anti-MRSA therapy discontinuation for pneumonia based on pharmacist involvement

Evaluation of Longitudinal Advanced Pharmacy Practice Experience Block Programs on Student and Program Outcomes

Cassidy Kemp, PharmD; PGY2 HSPAL Pharmacy Resident

Describe current LAPPE programs including student and program outcomes

Impact of weight- or BSA-based hydrocortisone dosing on outcomes in patients with septic shock

Logan Boone, PharmD; PGY2 Critical Care Pharmacy Resident

Determine if varying hydrocortisone dosing strategies influence time to shock reversal

Evaluation of Safety of Tacrolimus in the Non-Transplant Hospital Setting

Scott Gourley, PharmD; PGY1 HSPAL Pharmacy Resident

Describe recent research pertaining to tacrolimus related medication errors and its importance of continuation in a non-transplant hospital

Fee

$30.00

CE Hours

3.50

CE Units

0.350

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Requirements for CE Credit

In order to receive credit for this home study program, participants must:

Read the learning objectives and faculty disclosures
Review the video presentation and engage in any suggested interactivity
Complete the program evaluation form.

In order for credit to be transmitted to the NABP CPE Monitor, participants must provide their month and day of birth and NABP e-Profile ID number. Registration with a proper disclosure of the NABP E-Id is a requirement for receiving Continuing Pharmacy Education. To register with NABP CPE Monitor or look up your NABP E-profile ID, please click on the CPE Monitor logo below to be directed to their site. Failure to follow this process within the required timeframe will result in loss of credit. If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-profile.

Please choose a Fee Type from the Drop Down Menu Below:

I am a

Pharmacy Residency Research Showcase 2023: Part 1

At the conclusion of this activity, the participant will be able to:

Review and quantify overall effectiveness of atypical antipsychotics on reduction in the amount of continuous infusion propofol utilized in the ICU
Recognize potential contributors to acute kidney injury in patients receiving hypertonic saline
Describe the safety and effectiveness of chronic antibiotic suppression therapy for patients with a left ventricular assist device (LVAD)
Determine the proportion of patients who experienced treatment-emergent adverse events (TEAE) while receiving dalbavancin suppressive therapy
Describe the safety and efficacy of SGLT2 inhibitors observed in patients supported by an LVAD
Discuss the clinical treatment outcomes of cabotegravir/rilpivirine long-acting injectable when administered every 8 weeks in obese patients
Identify the utility of procalcitonin’s on antibiotic duration of therapy in pediatric sickle cell patients with fever

Speaker(s)/Author(s)

Allyson Barnett, PharmD PGY2 Critical Care Pharmacy Resident, Prisma Health Richland Hospital
Erik Preheim, PharmD PGY1 Ambulatory Care Pharmacy Resident, Prisma Health Richland
Hannah Robinson, PharmD PGY2 Pediatric Pharmacy Resident, Prisma Health Children's Hospital - Midlands
Jake Crocker, PharmD PGY2 Infectious Diseases Pharmacy Resident, Prisma Health Richland
Kelsey Hamlin Furtick, PharmD PGY2 Critical Care Pharmacy Resident, Prisma Health Midlands
Michael K. Shaw, PharmD PGY2 Infectious Diseases Pharmacy Resident, Prisma Health Richland
Y. Vivian Tsai, PharmD Infectious Diseases Clinical Pharmacy Fellow, Prisma Health Richland - University of South Carolina

Activity Number

0062-9999-23-122-H01-P

Release Date: Jul 3, 2023

Credit Expiration Date: Jul 3, 2026

CE Hours

1.75

Location

Prisma Health Richland

Pharmacy Residency Research Showcase 2023: Part 2

At the completion of this activity, the participant will be able to:

Describe the role of cerebrospinal fluid (CSF) lactate concentration as an indicator of infection in patients who have an external ventricular drain (EVD) or ventriculoperitoneal (VP) shunt
Identify barriers to consistent, sustainable access of SGLT2 inhibitors for the treatment of heart failure
Describe the impact of a conservative anticoagulation protocol following GIB on clinical outcomes in patients with a HM3 LVAD
Determine the difference in time to anti-MRSA therapy discontinuation for pneumonia based on pharmacist involvement
Describe current LAPPE programs including student and program outcomes
Determine if varying hydrocortisone dosing strategies influence time to shock reversal
Describe recent research pertaining to tacrolimus related medication errors and its importance of continuation in a non-transplant hospital

Speaker(s)/Author(s)

Abbie L. Blunier, PharmD PGY2 Infectious Diseases Pharmacy Resident, Prisma Health Richland
Benjamin Tabor, PharmD PGY2 Cardiology Pharmacy Resident, Prisma Health Richland
Cassidy H. Kemp, PharmD PGY2 Health System Pharmacy Administration and Leadership (HSPAL) Resident, Prisma Health Richland Hospital
Logan Boone, PharmD PGY2 Critical Care Pharmacy Resident, Prisma Health Richland Hospital
Lucy Rinehuls, PharmD PGY1 Ambulatory Care Pharmacy Resident, Prisma Health
Scott Gourley, PharmD, MBA PGY2 HSPAL Pharmacy Resident, Prisma Health Richland
Tamia Jones, PharmD PGY2 Internal Medicine Pharmacy Resident, Prisma Health

Activity Number

0062-9999-23-123-H01-P

Release Date: Jul 3, 2023

Credit Expiration Date: Jul 3, 2026

CE Hours

1.75